LONDON, UK, 4 March 2025 - In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumours (NETs), a ...

Among ionising radiation, alpha and beta particles are charged particles that have widely attracted research attention because of their use in a number of applications including smoke detectors, ...

In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...

Alpha DaRT, a unique localized alpha radiation therapy, has shown potential best-in-class efficacy and safety across multiple solid tumors. Currently enrolling patients in cSCC, HNSCC, pancreatic, and ...

Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - ...

Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim safety ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current ...

Alpha Tau Medical Ltd., a company specializing in innovative alpha-radiation cancer therapy, announced that CFO Raphi Levy will present at two investor conferences in May 2025. He will participate in ...

- Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first two patients - - Immune markers demonstrate immune system preservation ...

A part of Rutherford’s scattering experiments, this particular experiment involved shooting alpha particles at a piece of gold foil with the source, foil, and detector placed in a vacuum vessel.